Oral dosage forms for modified release comprising tasocitinib
- 专利权人:
- Ratiopharm GmbH
- 发明人:
- Stefan, Ralph,Sievert, Frank
- 申请号：
- AU2012210777
- 公开号：
- AU2012210777B2
- 申请日:
- 2012.01.26
- 申请国别(地区):
- AU
- 年份:
- 2015
- 代理人:
- 摘要：
- The invention essentially relates to oral dosage forms comprising a JAK3 inhibitor, preferably tasocitinib, suitable for modified release, and processes of preparing such oral dosage forms.
- 来源网站：
- 中国工程科技知识中心
